Skip to main content
. Author manuscript; available in PMC: 2022 Jul 8.
Published in final edited form as: Toxicol Appl Pharmacol. 2021 Dec 18;438:115830. doi: 10.1016/j.taap.2021.115830

Figure 3:

Figure 3:

Measured concentrations of dibenzo[def,p]chrysene (DBC) and DBC metabolites in blood and urine of mice following an oral dose of 15 mg/kg. Data points represent mean measured levels of DBC and its metabolites in plasma (A) and urine (B). Error bars represent standard deviations. Lines represent physiologically based pharmacokinetic (PBPK) model simulations of data.